Abstract
: Carbapenemase producing bacteria frequently possess resistance mechanisms to a wide-range of antibacterial agents, and are associated with high mortality and morbidity rates. Some enzymes like extended-spectrum β-lactamase (ESBL), New Delhi metallo-beta-lactamase-1 (NDM-1), Klebsiella pneumoniae carbapenemase (KPC), and OXA-producing Enterobacteriaceae are very important in frequently isolated nosocomial bacteria, which cause resistant to many classes of drugs. NDM-1 or KPCs, is a worldwide health problem which is slowly increasing. There is no vaccine to prevent infections produced by carbapenem-resistant bacteria.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
